Alterations in cyclic nucleotide phosphodiesterase activities in omental and subcutaneous adipose tissues in human obesity
Open Access
- 8 August 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nutrition & Diabetes
- Vol. 1 (8), e13
- https://doi.org/10.1038/nutd.2011.9
Abstract
Objective: To elucidate the activity and expression of cyclic nucleotide phosphodiesterase (PDE) families in omental (OM) and subcutaneous (SC) adipose tissue and adipocytes, and to study alterations in their activity in human obesity. Design: Cross-sectional, translational research study. Patients: In total, 25 obese and 9 non-obese subjects undergoing gastrointestinal surgery participated in the study. Results: Inverse correlations between PDE activities and body mass index (BMI) were seen in both SC and OM adipose tissue. Inverse correlations between total PDE and PDE3 activity and BMI were seen in OM adipocytes but not in SC adipocytes. In both SC and OM adipose tissue of obese patients, total PDE and PDE3 activities were decreased compared with the controls. In SC adipose tissue of Type 2 diabetes (T2D) patients, the PDE activity not inhibitable by PDE3 or PDE4 inhibitors (PDEn) was increased compared with obese non-diabetic patients. In addition to PDE3 and 4 isoforms, PDE7B, PDE9A and PDE10A proteins were also detected in adipose tissue or adipocytes. Conclusions: Multiple PDE families are present in human adipose tissue and their activities are differentially affected by obesity and T2D.Keywords
This publication has 35 references indexed in Scilit:
- Lipid-induced insulin resistance: unravelling the mechanismThe Lancet, 2010
- Apremilast, a cAMP phosphodiesterase‐4 inhibitor, demonstrates anti‐inflammatory activity in vitro and in a model of psoriasisBritish Journal of Pharmacology, 2010
- Reduced Adiposity and High-Fat Diet-Induced Adipose Inflammation in Mice Deficient for Phosphodiesterase 4BEndocrinology, 2009
- Phosphodiesterase‐5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide‐mediated lipolysisBritish Journal of Pharmacology, 2007
- Long-term regulation of cyclic nucleotide phosphodiesterase type 3B and 4 in 3T3-L1 adipocytesBiochemical and Biophysical Research Communications, 2007
- Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B–null miceJCI Insight, 2006
- The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysisJournal of Lipid Research, 2005
- Functional and Pharmacological Characterization of the Natriuretic Peptide-Dependent Lipolytic Pathway in Human Fat CellsThe Journal of pharmacology and experimental therapeutics, 2003
- Cyclic nucleotide phosphodiesterasesJournal of Allergy and Clinical Immunology, 2001
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976